TCAsSNRIs

TCAs and SNRIs are classes of antidepressant medications. TCAs, or tricyclic antidepressants, were among the first antidepressants developed and work by increasing the levels of neurotransmitters like serotonin and norepinephrine in the brain. They are often used to treat depression, anxiety disorders, and neuropathic pain. However, they can have a range of side effects, including dry mouth, constipation, blurred vision, and dizziness, and may carry a risk of cardiovascular issues in some individuals.

SNRIs, or serotonin-norepinephrine reuptake inhibitors, are a newer class of antidepressants. Like TCAs, they work by affecting serotonin and norepinephrine levels, but generally do so with a more targeted mechanism and potentially fewer side effects than TCAs. SNRIs are prescribed for depression, generalized anxiety disorder, social anxiety disorder, and panic disorder. Common side effects can include nausea, headache, insomnia, and sexual dysfunction. Both TCAs and SNRIs are prescription medications and their use should be carefully monitored by a healthcare professional. The choice between these medication classes depends on individual patient needs, medical history, and potential for side effects.